Corpus 1,273 assessed · 1,174 scored · 643 reproduced ≥75 · 169 flagged ·∅ 74.1/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: 1 ✕ human prostate cancer ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential. PMID 36450752	Nat Commun	2022	70	L1 70/100
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer. ⚑ PMID 32365491	Cancers (Basel)	2020	35	L1 35/100 ⚑

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.

PMID 36450752 · Nat Commun · 2022

L1 70/100

Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer.⚑

PMID 32365491 · Cancers (Basel) · 2020

L1 35/100 ⚑